Ozempic and Wegovy both contain semaglutide, but they're approved for different purposes and dosing. Ozempic is FDA-approved for type 2 diabetes management with maximum dose of 2.0 mg weekly. Wegovy is specifically approved for chronic weight management with higher maximum dose of 2.4 mg weekly. Both use the same active ingredient and mechanism - they mimic GLP-1 hormone to reduce appetite and slow gastric emptying. The main differences are branding, dosing protocols, and insurance coverage patterns. Some insurance plans cover Ozempic more readily for diabetes while requiring additional documentation for Wegovy weight loss coverage.
Find a qualified GLP-1 provider
Compare pricing, clinical oversight, and patient reviews across verified telehealth programs and local clinics.
Compare Providers →Still have questions?
A qualified GLP-1 provider can give you personalized answers based on your medical history and goals.
Get answers to your GLP-1 questions
Weekly updates with the latest research, pricing changes, and expert guidance — delivered to your inbox.
No spam. Unsubscribe anytime.
Ready to start your GLP-1 journey?
Compare verified providers on pricing, medication sourcing, clinical oversight, and patient reviews — all in one place.